282 related articles for article (PubMed ID: 11721759)
1. Costs of care for irritable bowel syndrome patients in a health maintenance organization.
Levy RL; Von Korff M; Whitehead WE; Stang P; Saunders K; Jhingran P; Barghout V; Feld AD
Am J Gastroenterol; 2001 Nov; 96(11):3122-9. PubMed ID: 11721759
[TBL] [Abstract][Full Text] [Related]
2. The economic consequences of irritable bowel syndrome: a US employer perspective.
Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
[TBL] [Abstract][Full Text] [Related]
3. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity in irritable bowel syndrome.
Whitehead WE; Palsson OS; Levy RR; Feld AD; Turner M; Von Korff M
Am J Gastroenterol; 2007 Dec; 102(12):2767-76. PubMed ID: 17900326
[TBL] [Abstract][Full Text] [Related]
5. Gastro-oesophageal acid-related disease, co-morbidity and medical care cost.
Jayadevappa R; Chhatre S; Weiner M
Chronic Illn; 2008 Sep; 4(3):209-18. PubMed ID: 18796510
[TBL] [Abstract][Full Text] [Related]
6. Patients with irritable bowel syndrome: health status and use of health care services.
Donker GA; Foets M; Spreeuwenberg P
Br J Gen Pract; 1999 Oct; 49(447):787-92. PubMed ID: 10885081
[TBL] [Abstract][Full Text] [Related]
7. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
[TBL] [Abstract][Full Text] [Related]
8. Societal costs for irritable bowel syndrome--a population based study.
Hillilä MT; Färkkilä NJ; Färkkilä MA
Scand J Gastroenterol; 2010 May; 45(5):582-91. PubMed ID: 20166844
[TBL] [Abstract][Full Text] [Related]
9. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
[TBL] [Abstract][Full Text] [Related]
10. Review article: epidemiology and quality of life in functional gastrointestinal disorders.
Chang L
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():31-9. PubMed ID: 15521853
[TBL] [Abstract][Full Text] [Related]
11. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and physiological sleep characteristics in women with irritable bowel syndrome.
Elsenbruch S; Thompson JJ; Hamish MJ; Exton MS; Orr WC
Am J Gastroenterol; 2002 Sep; 97(9):2306-14. PubMed ID: 12358249
[TBL] [Abstract][Full Text] [Related]
13. Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients?
Sach J; Bolus R; Fitzgerald L; Naliboff BD; Chang L; Mayer EA
Am J Gastroenterol; 2002 Dec; 97(12):3131-8. PubMed ID: 12492200
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study.
Goettsch WG; van den Boom G; Breekveldt-Postma NS; Smout AJ; Herings RM
Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):803-10. PubMed ID: 15386693
[TBL] [Abstract][Full Text] [Related]
15. Health care utilization and cost among health maintenance organization members with temporomandibular disorders.
White BA; Williams LA; Leben JR
J Orofac Pain; 2001; 15(2):158-69. PubMed ID: 11443827
[TBL] [Abstract][Full Text] [Related]
16. The economics of laparoscopic Nissen fundoplication.
Dire CA; Jones MP; Rulyak SJ; Kahrilas PJ
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):328-32. PubMed ID: 15017676
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and care of irritable bowel syndrome in a community-based population.
Yawn BP; Locke GR; Lydick E; Wollan PC; Bertram SL; Kurland MJ
Am J Manag Care; 2001 Jun; 7(6):585-92. PubMed ID: 11439732
[TBL] [Abstract][Full Text] [Related]
18. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity and use of health-care services among irritable bowel syndrome sufferers.
Hillilä MT; Siivola MT; Färkkilä MA
Scand J Gastroenterol; 2007 Jul; 42(7):799-806. PubMed ID: 17558902
[TBL] [Abstract][Full Text] [Related]
20. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
